Literature DB >> 6379418

Interaction of human complement proteins with serum-sensitive and serum-resistant strains of Escherichia coli.

P W Taylor, H P Kroll.   

Abstract

Exposure of serum-susceptible Escherichia coli strains to lethal concns of lysozyme-free human serum resulted in stable binding of complement components to the outer membrane (OM), but not to the cytoplasmic membrane (CM). The short prekilling phase of the reaction was accompanied by binding of C3b; loss of viability was immediately preceeded by stable deposition onto the OM of the component proteins of the membrane attack complex. During the early stages of the active killing phase, bound monomeric C9 could be resolved into two distinct bands on SDS-polyacrylamide gels. Serum exposure lead to a progressive loss of CM recoverability, which appeared to result from partial degradation of CM phospholipids. In contrast, exposure of a resistant E, coli strain to human serum resulted in little change in the membrane profile and very little stable deposition of terminal complement components onto the OM.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6379418     DOI: 10.1016/0161-5890(84)90046-4

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  13 in total

1.  Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa.

Authors:  N L Schiller; K A Joiner
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

2.  Lipopolysaccharide phase variation determines the complement-mediated serum susceptibility of Coxiella burnetii.

Authors:  S Vishwanath; T Hackstadt
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

3.  Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis.

Authors:  C M Fernandez-Prada; M Nikolich; R Vemulapalli; N Sriranganathan; S M Boyle; G G Schurig; T L Hadfield; D L Hoover
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Kinetics of assembly and decay of complement components on Escherichia coli O111:B4 preparation of stable intermediates.

Authors:  G Rottini; F Tedesco; M Basaglia; L Roncelli; P Patriarca
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

5.  Bacterial killing by complement. C9-mediated killing in the absence of C5b-8.

Authors:  J R Dankert; A F Esser
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

6.  C9-mediated killing of bacterial cells by transferred C5b-8 complexes: transferred C5b-9 complexes are nonbactericidal.

Authors:  K P Blanchard; J R Dankert
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

7.  Affinity of the C9 molecule for the C5b-8 complex compared with that for the complex containing C9 molecules.

Authors:  S L MacKay; J R Dankert
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

8.  A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes.

Authors:  G Sandström; S Löfgren; A Tärnvik
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

9.  Killing of gram-negative bacteria by complement. Fractionation of cell membranes after complement C5b-9 deposition on to the surface of Salmonella minnesota Re595.

Authors:  S Tomlinson; P W Taylor; B P Morgan; J P Luzio
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

10.  Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9.

Authors:  K A Joiner; M A Schmetz; M E Sanders; T G Murray; C H Hammer; R Dourmashkin; M M Frank
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.